Bradley Pharmaceuticals, Inc. establishes new active scientific advisory board.FAIRFIELD, N.J.--April 30, 1996--(BUSINESS WIRE)--BRADLEY PHARMACEUTICALS, INC. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on NM: BPRXA) announced today that it has named ten members to its new Scientific Advisory Board. The Scientific Advisory Board, chaired by Dr. Albert Fleischner, Bradley Pharmaceuticals, Inc. Vice President of Pharmaceutical Research and Development, was formed in order to meet the technological challenges of the future in the industry. "We're looking forward to working closely with our Advisory Board to develop the new concepts and products that will advance Bradley," said Dr. Fleischner. "Our Scientific Advisory Board will be active and involved participants who will help guide us on a project by project basis, with each member contributing from his particular area of expertise. We feel that the diversity of knowledge represented on our Scientific Advisory Board will give us a unique perspective on the future of the pharmaceutical industry." The new Scientific Advisory Board is comprised of the following members: Myren Arlen, MD, an internationally renowned oncologist and tumerologist, with over 80 publications and authorship of two textbooks in oncology, tumerology and cancer surgery. Dr. Arlen is a graduate of Down State Medical. Alan M. Goldberg, PhD, a professor of toxicology, is director of the Center for Alternatives to Animal Testing The Johns Hopkins University Center for Alternatives to Animal Testing (CAAT) [1] has worked with scientists since 1981 to find new methods to replace the use of laboratory animals in experiments, reduce the number of animals tested, and refine necessary tests to and the associate dean for corporate affairs at the Johns Hopkins School of Public Health, who specializes in the use of non-animal methods in product safety evaluation. Dr. Goldberg, who has over 100 publications and has authored or edited more than 15 books, is a graduate of the Arnold and Marie Schwartz College of Pharmacy A college of pharmacy generally refers to a tertiary educational institution (or part of such an institution) which is involved in the education of future pharmacists and pharmaconomists. . He received his PhD from the University of Minnesota (body, education) University of Minnesota - The home of Gopher. http://umn.edu/. Address: Minneapolis, Minnesota, USA. . Cory A. Golloub, MD, is a doctor of internal medicine and pediatrics who received his B.S. from SUNY SUNY - State University of New York Stony Brook, and his MD from the University of Medicine, Tampico, Mexico, with postgraduate affiliations at SUNY Downstate-Brookdale Hospital and UMDNJ-New Jersey Medical School. He is currently affiliated with UMDNJ-NJMS, University Hospital and Chilton Memorial Hospital Chilton Memorial Hospital, located at 97 West Parkway in Pompton Plains, is the only hospital serving the Pequannock Township area. Chilton is a non-profit community hospital. in New Jersey. Stephen M. Gross, EdD, the Dean of the Arnold and Marie Schwartz College of Pharmacy & Health Sciences, as well as of the School of Health Professions, Long Island University. The author of numerous articles in the area of pharmacy administration, Dr. Gross was a member of the prior Scientific Advisory Board, and is also a member of the New York State Board of Pharmacy. Anthony LaVia is the retired Vice President of the Convatec Division of Squibb, which specialized in the development and sale of ostomy products. Mr. LaVia was the developer of many of the Squibb products generally characterized as the beginning of modern pharmacy; after his retirement, he served as a consultant to Roberts Pharmaceutical, Inc. in the area of pharmaceutical development. Peter Pugliese, MD is internationally recognized for his expertise in the areas of skin care and skin physiology, having received many awards for his work in this field. He is the CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Milmark Research, a company devoted to skin research and contract manufacturing of topical products. Dr. Pugliese is a graduate of the University of Pennsylvania School of Medicine The University of Pennsylvania's School of Medicine, presently located in the University City section of Philadelphia, Pennsylvania, was the United States's first school of medicine, founded at the College of Philadelphia, as the University was then called. . Sheldon Rabin, MD, an ophthalmologist ophthalmologist /oph·thal·mol·o·gist/ (of?thal-mol´ah-jist) a physician who specializes in ophthalmology. oph·thal·mol·o·gist n. A physician who specializes in ophthalmology. specializing in the treatment of glaucoma, is currently involved in cancer vaccine research. Dr. Rabin is a graduate of Northwestern University. Bhogilal B. Sheth, PhD, is a professor in the Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee The University of Tennessee (UT), sometimes called the University of Tennessee at Knoxville (UT Knoxville or UTK), is the flagship institution of the statewide land-grant University of Tennessee public university system in the American state of Tennessee. at Memphis, and the current Director, Parenteral Medications Laboratories at the same institution. Mitchell J. Spirt, MD, a board certified gastroenterologist currently practicing in California, holds a B.S. from University Center of New York at Binghamton. He received his MD from Mount Sinai Medical Center. Gerald N. Wachs, MD, is a doctor of dermatology who received his B.S. and MD from the University of Illinois University of Illinois may refer to:
BRADLEY PHARMACEUTICALS, INC. markets and manufactures brandname prescription and over-the-counter pharmaceutical and health-related products, including respiratory, dermatologic, nutrition, personal hygiene and internal medicine brands. Bradley Common Class A shares, and Bradley Class A, B and D Warrants (BPRXA, BPRXW, BPRXZ and BPRXL, respectively) are traded on the Nasdaq National Market System. CONTACT: Alan V. Gallantar V.P. Chief Financial Officer Bradley Pharmaceuticals, Inc. (201) 885-1505, Ext. 266 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion